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Homologous to the E6AP carboxyl terminus (HECT) and regulator of chromosome 
condensation 1 (RCC1)-like domain-containing proteins (HERCs) belong to the superfamily 
of ubiquitin ligases. HERC proteins are divided into two subfamilies, Large and Small 
HERCs. Despite their similarities in terms of both structure and domains, these subfamilies 
are evolutionarily very distant and result from a convergence phenomenon rather than 
from a common origin. Large HERC genes, HERC1 and HERC2, are present in most 
metazoan taxa. They encode very large proteins (approximately 5,000 amino acid residues 
in a single polypeptide chain) that contain more than one RCC1-like domain as a structural 
characteristic. Accumulating evidences show that these unusually large proteins play key 
roles in a wide range of cellular functions which include neurodevelopment, DNA damage 
repair, and cell proliferation. To better understand the origin, evolution, and function of the 
Large HERC family, this minireview provides with an integrated overview of their structure 
and function and details their physiological implications. This study also highlights and 
discusses how dysregulation of these proteins is associated with severe human diseases 
such as neurological disorders and cancer.
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INTRODUCTION
Proteins containing a HECT domain are ubiquitin ligases (E3). These enzymes participate in 
the ubiquitylation process accepting ubiquitin from a ubiquitin-conjugating enzymes (E2) and 
catalysing its transfer to the protein to be  ubiquitylated (Buetow and Huang, 2016). In animals, 
HECT E3 ligases can be  divided into 16 groups including the Large HERC family (Marín, 
2010), which is the subject of the present minireview. This family is comprised by HERC1 
and HERC2, two gigantic proteins of close to 5,000 amino acid residues in a single polypeptide 
chain. They are the largest HECT-containing proteins1.
1 https://www.uniprot.org/uniprot/?query=reviewed%3Ayes+AND+organism%3A%22Homo+sapiens+%28Human%29+%5B
9606%5D%22&sort=mass; (Bateman et  al., 2017).
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LARGE HERCs EVOLUTIONARY 
INSIGHTS
Although traditionally classified together with the Small HERC 
proteins, Large and Small HERCs form two distant protein 
families (Marín, 2010). Large HERCs contain more than one 
RCC1-like domains (RLDs), differing from Small HERCs, which 
carry only one. Structural differences were observed between 
the RLDs in Large and Small HERCs (Hadjebi et  al., 2008). 
The explanation for the differences among these two protein 
groups is that they result from convergent evolution of ancestors 
belonging to distant families (Marín, 2010).
While HERC2 appears in some choanoflagellates such as 
Monosiga brevicollis and Salpingoeca rosetta, the emergence of 
HERC1 occurred in Metazoa. Both proteins are already present 
in the placozoan Trichoplax adhaerens and in most metazoan 
phyla, with the absence of HERC1  in certain insect clades 
(Marín, 2010). Phylogenetic analysis of Large HERCs amino 
acid sequences segregates them in two clusters: one for HERC1 
and one for HERC2; displaying higher similarity between 
orthologues (Figure 1). The phylogenetic relationships of the 
sequences within each cluster correlate with those in the 
evolution of the species. It is noteworthy that HERC2 from 
S. rosetta presents a SPRY domain, which is characteristic of 
HERC1 (Figure 2A; Garcia-Gonzalo et  al., 2005). However, it 
cannot be  considered homologous to that of T. adhaerens 
HERC1 [19.6% identity, e  =  0.17; as shown by BLAST-p 
comparison (Altschul et  al., 1997, 2005)]. Thus, this presence 
is likely due to convergence, a relatively frequent event in 
HECT proteins along evolution (Marín, 2010).
STRUCTURAL FEATURES OF LARGE 
HERCs
The RCC1-Like Domains, Structure,  
and Function
The presence of RLDs is a structural feature of Large HERCs 
(Figure 2A). RCC1 is necessary for maintaining chromosomes 
decondensed during DNA replication. It is also a guanine 
exchange factor (GEF) for the GTPase Ran, a nuclear import 
protein (Nishimoto et  al., 1978; Bischoff and Ponstingl, 1991). 
RCC1 tertiary structure is composed of seven β blades resembling 
the shape of a propeller (Figure 2B; first panel). Structure 
prediction models have been used since three-dimensional 
structure determination of Large HERCs has not been possible 
to date (Waterhouse et  al., 2018). Large HERC RLDs structure 
is very similar to that of RCC1 (Figure 2B; framed panels).
HERC1 is implicated in intracellular vesicle trafficking by 
interacting through its RLD2 with ARF1 and Clathrin 
(Rosa et  al., 1996; Rosa and Barbacid, 1997). HERC1 RLD1 
may also function as a GDP releasing factor (GRF) for 
ARF proteins in the presence of phosphatidylinositol- 
4,5-bisphosphate (Garcia-Gonzalo et  al., 2004, 2005). As a 
small GTPase regulator, HERC1 interacts, among others, with 
IQGAP1, which is a key interactor centre for such proteins 
(Jacquemet and Humphries, 2013). No GEF or GRF activities 
have been reported in HERC2. Of note, HERC2 forms a 
complex with and stimulates the E6AP ubiquitin ligase activity 
through its RLD2 (Kuhnle et  al., 2011).
HECT Domain Structure and Function: 
Ubiquitin Ligase Activity
Large HERCs display a HECT domain at their carboxyl end. 
In silico predicted models show structural similarity with the 
HECT domain of E6AP (Figure 2C). They form a bilobed 
structure consisting of a helix-turn-helix motif packed with 
two and four antiparallel β sheets at the N and C ends, 
respectively. The lobes are joined to the hinge formed by a 
core of α helices. This bilobed structure facilitates transmission 
of the ubiquitin residue to its target protein. Thus, the 
N-terminal-facing lobe is able to bind the E2 enzyme from 
which the ubiquityl residue is transferred to the catalytic cysteine 
within the C-terminal-facing lobe of the domain (Figure 2C; 
circled). Following that, the ubiquitin is transferred to a lysyl 
residue or to the amino terminus in the target protein 
(Metzger et  al., 2012; Streich and Lima, 2014).
Large HERCs play a role in protein stability. HERC1 regulates 
C-RAF stability through ubiquitylation leading to proteasomal 
degradation (Schneider et  al., 2018) and is also implicated in 
the stability of TSC2/tuberin (Chong-Kopera et  al., 2006). 
HERC2 ubiquitylates for proteasomal degradation proteins 
involved in DNA repair such as XPA and BRCA1, Ubiquitin 
Specific Proteases (USP) such as USP33 and USP20, and proteins 
involved in iron metabolism such as FBXl5 and NCOA4 
(reviewed in Sánchez-Tena et  al., 2016). HERC2 also promotes 
degradation of the LKB1 kinase when acetylated (Bai et al., 2016).
PHYSIOLOGICAL IMPLICATIONS
Cancer and DNA Damage Repair
HERC2 is implicated in different types of cancer. In osteosarcoma, 
the increase of HERC2-binding protein SOX18 enhances cell 
proliferation correlating with a decrease in HERCs mRNA 
levels, especially those of HERC2 (Zhu et  al., 2018). Certain 
HERC2 genetic variants are risk factors in cutaneous and uveal 
melanomas (Ibarrola-Villava et  al., 2010; Amos et  al., 2011; 
Kosiniak-Kamysz et al., 2014). Frameshift mutations in HERC2 
have been described in gastric and colorectal carcinomas with 
microsatellite instability (Yoo et  al., 2011).
HERC2 is also implicated in DNA damage repair (DDR). 
HERC2 induces BRCA1 degradation in breast cancer. This 
is inhibited either by binding of TUSC4 to HERC2 (Peng 
et  al., 2015) or by BARD1 binding BRCA1 itself (Wu et  al., 
2010). Moreover, HERC2 targets XPA for degradation. ATR 
phosphorylates XPA thus preventing this ubiquitylation while 
WIP dephosphorylates XPA in a circadian manner (Kang 
et al., 2010, 2011; Lee et al., 2014). Besides, ATR phosphorylates 
and also stabilizes USP20 by unbinding it from HERC2. In 
turn, USP20 stabilizes Claspin, which increases the activity 
of the ATR-Chk1 axis (Yuan et  al., 2014; Zhu et  al., 2014). 
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On the other hand, HERC2 binds Claspin among other 
proteins upon MCM2 phosphorylation, and facilitates 
replication origin firing (Izawa et  al., 2011). In a different 
way, HERC2 promotes resistance to cisplatin and UV-induced 
DNA damage by stabilizing the Ubc13-RNF8 tandem and 
RNF168 and enhancing the recruitment of repair factors such 
as 53BP1, RAP80, and BRCA1 to the damaged sites (Bekker-
Jensen et al., 2010; Danielsen et al., 2012; Bonanno et al., 2016; 
Mohiuddin et  al., 2016). Ubc13-RNF8 binding is facilitated 
by HERC2 by interacting with the RNF8 FHA domain upon 
phosphorylation of threonine 4827 of HERC2 triggered by 
ionizing radiation (IR) (Bekker-Jensen et  al., 2010) and by 
acting as a docking platform upon DNA damage, when HERC2 
is SUMOylated by PIAS4 (Bekker-Jensen and Mailand, 2010; 
Danielsen et  al., 2012). Both RNF8 and RNF168 are required 
for ubiquitin foci formation upon IR (Oestergaard et  al., 
2012), which are necessary for DDR maintenance. In addition 
to that, HERC2 stabilizes USP16 which, in turn, deubiquitylates 
FIGURE 1 | Molecular phylogeny of Large HERC proteins. The tree shows the clustering of HERC1 (blue) and HERC2 (red) amino acid sequences from significative 
choanoflagellate and metazoan species. Ultrafast bootstrap support (1,000 replicates) is shown next to the branches in bold. Smaller numbers indicate branch 
lengths. NEDD4 protein from Monosiga brevicollis was used as a outgroup.
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FIGURE 2 | Structural features of Large HERC proteins. (A) Primary structure of human RCC-1, E6AP, HERC1, and HERC2 proteins. Scheme shows the 
approximate relative position of each significative protein domain as indicated by ScanProSite domain predictions with the amino acid sequences. (B,C) Three-
dimensional structures of homologous RCC1-like and HECT domains in HERC1 and HERC2. Three-dimensional structures of RCC1 and E6AP HECT domains were 
modelled using the Swiss-Model online software and used as a template for HERC1 and HERC2 RCC1-like (B) and HECT (C) domains modelling. Active-site 
cysteine location in the HECT domains is indicated by a pale yellow circle.
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histone 2A so as to terminate the DDR (Zhang et  al., 2014). 
Moreover, during S phase, HERC2 is necessary for RPA 
ubiquitylation which plays a role in clearing G-quadruplex 
DNA structures by binding the RecQ DNA helicases BLM 
and WRN (Wu et  al., 2018). Finally, HERC2 along with 
NEURL4 controls cell proliferation by regulating the 
transcriptional activity of the tumour suppressor protein p53 
through regulation of its oligomerization (Cubillos-Rojas et al., 
2014, 2017). All these data suggest that HERC2 functions 
to control the cell response to genotoxic insults and helps 
maintain genome stability.
HERC1 is also involved in DDR and cancer. HERC1 deletions 
affect MSH2 protein levels (Diouf et  al., 2011). Besides, it 
also promotes degradation of BAK in the presence of the E6 
protein from the HPV5β virus and prevents cell death in 
response to UV (Holloway et  al., 2015). Furthermore, HERC1 
is recurrently mutated in metastatic triple negative (Craig 
et  al., 2013) and in invasive lobular cancer in the breast 
(Ping et  al., 2016). In addition to that, an atypical HERC1-
PML transcript fusion mRNA (Walz et  al., 2010) and HERC1 
mutations are also found in leukaemia (Diouf et  al., 2011; 
Neumann et  al., 2015; Johansson et  al., 2018). HERC1 binds 
to the M2 isoform of pyruvate kinase, which is typically 
found in proliferating tissues and cancer cells although the 
physiological role for this association has not been elucidated 
to date (Garcia-Gonzalo et al., 2003; Mazurek, 2008). Moreover, 
as stated above, HERC1 regulates cell proliferation through 
C-RAF stability. In particular, accumulation of C-RAF upon 
HERC1 knockdown results in increased cell proliferation 
(Schneider et  al., 2018). Finally, one singular clinical case of 
pulmonary sclerosing pneumocytoma revealed several somatic 
mutations on HERC1 along with other genes such as TSC1 
and AKT1 (Fan et  al., 2018).
Development and Neurobiology
In mice, recessive mutations of the Herc2 gene are associated 
with defects in growth, motor coordination and fertility (Lehman 
et  al., 1998; Walkowicz et  al., 1999). While Herc2 knockout 
animals are not viable, heterozygous mice have motor impairment 
(Cubillos-Rojas et  al., 2016). In humans, the HERC2 gene 
locates to chromosome 15 among genes responsible for such 
disorders as Angelman and Prader-Willi syndromes and 
Autism spectrum disorders (Ji et  al., 1999; Dimitropoulos and 
Schultz, 2007; Roberts et  al., 2014). Recessive mutations in 
the HERC2 locus are related to symptoms ranging from 
cognitive delay, ataxia, speech disorders, microcephalia, 
seizures, facial dysmorphism, hypopigmentation, and other 
secondary signs such as infections and behavioural 
alterations (Puffenberger et  al., 2012; Harlalka et  al., 2013; 
Neubert et al., 2013; Han et al., 2016; Morice-Picard et al., 2016).
Little is known about the precise molecular mechanism by 
which HERC2 affects neuronal development and function. 
HERC2-NEURL4 complex binds RNF8  in neurons regulating 
synapse formation in vivo. Knockdown of HERC2 resembles 
the effects in RNF8 depletion and inhibition of RNF8-Ubc13 
signalling – an increase in parallel fibres, synaptic boutons, 
and synapse formation with Purkinje cells (Valnegri et al., 2017). 
HERC2 could also be  linked to other neurological diseases. 
Parkinson’s disease-associated kinase LRRK2 is known to bind 
to the HERC2-NEURL4 complex thus regulating endosomal 
vesicular trafficking and promoting the internalization of the 
Delta-like 1/Delta Notch ligand, affecting its signalling 
(Imai et  al., 2015).
HERC1 has also major implications in neurodevelopment. 
Herc1 Gly483Glu mutant mice, termed tambaleante, present 
with delayed growth, short body, high juvenile mortality, and 
severe ataxia, the latter due to Purkinje cell loss beyond the 
age of 2  months, correlating with autophagy and decreased 
mTOR signalling (Mashimo et  al., 2009). Tambaleante mice 
have impaired neurotransmitter release in neuromuscular 
junctions (Bachiller et al., 2015), defective ubiquitin-proteasome-
driven protein aggregate clearance, and increased autophagic 
flux in neocortical pyramidal, CA3 hippocampal pyramidal 
and spinal cord motor neurons (Ruiz et  al., 2016) and poor 
myelinisation and delayed action potential transmission (Bachiller 
et  al., 2018). Furthermore, they have impaired associative 
learning (Perez-Villegas et  al., 2018). In humans, patients with 
recessive mutations of HERC1 present with intellectual disability, 
macrocephalia, facial dysmorphism, feeding difficulties, 
kyphoscoliosis, thicker corpus callosum, seizures, and other 
clinical signs resembling autism (Ortega-Recalde et  al., 2015; 
Aggarwal et al., 2016; Hashimoto et al., 2016; Nguyen et al., 2016; 
Kannan et  al., 2017; Utine et  al., 2017).
Other Processes
The human HERC2 gene locus is upstream of that of the 
OCA2 gene (mutated in oculocutaneous albinism) and certain 
HERC2 SNPs can interfere OCA2’s expression thus affecting 
eye, skin, and hair pigmentation (Eiberg et  al., 2008; Kayser 
et  al., 2008; Sturm et  al., 2008; Branicki et  al., 2009; Nan 
et  al., 2009). Certain phenotypes are favoured by evolution 
with a traceable population gradient from Europe to Asia (Ulivi 
et  al., 2013; Wilde et  al., 2014). Moreover, polymorphisms in 
the HERC2 locus relate to rosacea (Aponte et al., 2018), macular 
degeneration (Klein et  al., 2014), vitiligo (Jin et  al., 2012), 
and skin photosensitivity (Hernando et al., 2018). As for HERC1, 
some of its catalogued polymorphisms are more likely to occur 
in the East Asian population than in the rest of the world 
(Xue et  al., 2009; Yuasa et  al., 2009).
HERC2 is also related to inflammation and autoimmune 
diseases such as Crohn’s disease, ulcerative colitis, type 1 diabetes 
mellitus, or sarcoidosis (Franke et  al., 2008; Weersma et  al., 
2009; Wang et  al., 2010; Fischer et  al., 2011; Garcia-Heredia 
and Carnero, 2017). With regard to HERC1, a downregulation 
of its expression has been observed in an LPS-induced 
inflammation model following coenzyme Q10 treatment. 
(Schmelzer and Doring, 2010).
In addition to this, HERC2 is involved in iron metabolism 
and ferritinophagy by regulating stability of FBXL5, IRP2, 
and NCOA4 proteins (Moroishi et  al., 2011, 2014; Galligan 
et  al., 2015; Mancias et  al., 2015; Ryu et  al., 2018) and in 
toxicology to the response to diisocyanate, toluene, or alcohol 
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intake (Sulovari et  al., 2015; Yucesoy et  al., 2015; Lim et  al., 
2017). In regard to toxicology, HERC1 may also play a 
role in the response of the nervous system to heroin 
(Drakenberg et  al., 2006).
FINAL REMARKS
Large-HERC family members are staggeringly complex proteins 
that can intervene in a wide range of physiological processes, 
such as proliferation, DNA repair, neurodevelopment, 
inflammation, or ferritinophagy among others. HERC1 and 
HERC2 sequences are quite conserved through animal evolution, 
evolving linearly together with the increase of complexity in 
nervous, endocrine, and immune systems of organisms. Mutations 
or reduced expression of Large HERCs are associated with 
neurological disorders, DNA repair defects, and cancer pointing 
out the importance that Large HERC proteins have in the 
abovementioned physiological processes.
FIGURE SOURCES
Amino acid sequences were aligned using the Mafft FFT-NS-i 
algorithm (Katoh, 2002). The phylogenetic tree in Figure 1 
was inferred using the maximum likelihood method with 
IQ-Tree 1.6.9 software (Nguyen et  al., 2015). The model used 
for the analysis was JTT  +  F  +  G4, determined using 
ModelFinder (Kalyaanamoorthy et  al., 2017). The IQ-Tree 
search parameters were set to perturbation strength  =  0.8 
and 500 unsuccessful iterations to stop (numstop  =  500). 
Ultrafast Bootstrap support (Hoang et al., 2018) was calculated 
from 1,000 replicates. The final tree obtained with IQ-Tree 
was visualized using Interactive Tree of Life v4 (Letunic and 
Bork, 2019). NEDD4 protein from M. brevicollis was used 
as an outgroup. The accession numbers of the sequences used 
are: for NEDD4: M. brevicollis (XP_001750085.1), for HERC1: 
T. adhaerens (XP_002116356.1), Anoplophora glabripennis 
(Asian long-horned beetle) (XP_018567016.1), Callorhinchus 
milii (Elephant shark) (XP_007906088.1), Latimeria 
chalumnae (Coelacanth) (XP_005987767.1), Danio rerio 
(Zebrafish) (XP_021333511.1), Oreochromis niloticus (Tilapia) 
(XP_013121789.1), Xenopus tropicalis (Frog) (XP_004916026.1), 
Gekko japonicus (Gecko) (XP_015275623.1), Gallus gallus 
(Chicken) (XP_004943789.1), Ornithorhynchus anatinus 
(Platypus) (XP_028921613), Monodelphis domestica (Opossum) 
(XP_016284147.1), Sarcophilus harrisii (Tasmanian devil) 
(XP_023353554.1), Equus caballus (Horse) (XP_023471806.1), 
Rattus norvegicus (Rat) (XP_017451567.1), Mus musculus 
(Mouse) (NP_663592.3), Homo sapiens (Human) (NP_003913.3), 
Pan troglodytes (Chimpanzee) (XP_001174017.1), Canis 
lupus familiaris (Dog) (XP_544717.3), Felis catus (Cat) 
(XP_023110993.1), and Lepidosiren paradoxa (Lungfish) 
(Translated from GEHZ01042047.1, NCBI TSA database). 
For HERC2: M. brevicollis (XP_001743304.1), S. rosetta 
(XP_004996155.1), T. adhaerens (XP_002112421), Asian long-horned 
beetle (XP_018562376.1), Drosophila melanogaster (Fruit fly) 
(NP_608388.2), Apis mellifera (Honey bee) (XP_01677273), 
Coelacanth (XP_014343905.1), Zebrafish (XP_021332870.1), 
Tilapia (XP_013130527.1), Frog (XP_012813156.1), Gecko 
(XP_015266462.1), Chicken (XP_015133197.1), Platypus 
(XP_016083014.1), Opossum (XP_007501467.1), Tasmanian 
devil (XP_023356163.1), Horse (XP_023507879.1), Mouse 
(NP_001347009.1), Rat (XP_006229362.1), Human (NP_004658.3), 
Chimpanzee (XP_024204823.1), Dog (XP_022272508.1), Cat 
(XP_023110801.1), Elephant shark (XP_007889299.1), and Lungfish 
(Translated from GEHZ01036559.1, NCBI TSA).
Human RCC1 (NCBI accession number P18754) and HECT 
domain from E6AP (NCBI accession number Q05086.4, amino 
acids from 518 to 869) three-dimensional structures were 
modelled using Swiss-Model online software (Waterhouse et al., 
2018). RLDs and HECT domains from HERC1 and HERC2 
were modelled using a User Template mode. The query 
sequences were the following: Q15751 for HERC1 (amino 
acids 371–736 and 3996–4361 for RLD1 and RLD2, respectively, 
and 4501–4848 for the HECT domain) and O95714 for HERC2 
(amino acids 415–778, 2958–3327 and 3951–4319 for RLD1, 
RLD2, and RLD3, respectively, and 4457–4794 for the HECT 
domain). PDB files from RCC1 and E6AP HECT domain 
models obtained as described above were used as templates 
in these queries. The amino acid position of each domain 
identified was verified using ScanProSite domain predictions 
(Sigrist et  al., 2012).
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